Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Randall Kaye currently holds 175,946 shares of AVANIR PHARMACEUTICALS, INC. (AVNR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Randall Kaye has been a net seller of AVNR stock. They have purchased $45.4K and sold $1.9M worth of shares.
Randall Kaye's most recent insider trade was on Dec 2, 2024, when they sold 9,500 shares at $0.00 per share.
Randall Kaye serves as Executive at AVANIR PHARMACEUTICALS, INC. (AVNR). They have executed 64 insider transactions totaling $1.9M over their tenure at the company.
Randall Kaye holds the position of Executive at AVANIR PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Randall Kaye has shown a selling trading pattern, with $45.4K in total purchases and $1.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Randall Kaye was on Aug 12, 2024, when they sold $361.9K worth of LBPH shares. This transaction involved 10,476 shares at $34.55 per share.
Randall Kaye currently owns 175,946 shares of AVANIR PHARMACEUTICALS, INC. (AVNR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Randall Kaye's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Randall Kaye has 64 Form 4 filings on record as an insider at AVANIR PHARMACEUTICALS, INC..
Set alerts for Randall Kaye and 40,000+ other insiders.